Citigroup’s Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 AMSGP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-3,089
Closed -$446K 7320
2016
Q2
$446K Sell
3,089
-29,684
-91% -$4.31M ﹤0.01% 3791
2016
Q1
$4.67M Sell
32,773
-52,351
-61% -$7.04M 0.01% 1620
2015
Q4
$12.2M Sell
85,124
-6,854
-7% -$1.03M 0.01% 1018
2015
Q3
$13.5M Sell
91,978
-40,887
-31% -$6.2M 0.01% 933
2015
Q2
$18.5M Buy
+132,865
New +$17.7M 0.02% 823
2015
Q1
Sell
-7,151
Closed -$808K 7635
2014
Q4
$808K Sell
7,151
-122,725
-94% -$13.2M ﹤0.01% 3361
2014
Q3
$13.9M Buy
+129,876
New +$14M 0.01% 1042

Other funds holding AMSGP

Citigroup's AMSGP Position: Q3 2016 in Review

Citigroup sold out of Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 (AMSGP) in Q3 2016, closing a stake of 3,089 shares — an estimated $446K sold.

Citigroup first reported a position in AMSGP in Q3 2014 and held it in 7 quarters. The position peaked at $18.5M in Q2 2015. 21 funds tracked by Wall St. Rank hold AMSGP as of Q3 2016.

  • Citigroup reported no remaining Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 position as of Q3 2016 after selling out during the quarter.
  • Citigroup sold 3,089 Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 shares in Q3 2016, an estimated $446K.
  • Citigroup first reported a position in Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 in Q3 2014 and held it in 7 quarters.
  • Citigroup's Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 position peaked at $18.5M in Q2 2015.
  • 21 funds tracked by Wall St. Rank held Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 as of Q3 2016.

Based on Citigroup's 13F filing for Q3 2016, filed 10 Nov 2016.